The Potential Use of Parenteral Dipeptides in Clinical Nutrition

  • P. Fürst
  • P. Stehle
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine 1993 book series (YEARBOOK, volume 1993)


Few areas of medical research and development have been the scene of such substantial and valuable progress as has the recent surge of research in artificial nutrition. Inevitably, this progress is largely interdependent on the current biochemical knowledge and recent discoveries with regard to cellular bioenergetics and transport mechanisms. The dramatic revolution in molecular biology provides novel therapeutical means on condition that these new gains in technology become available in the clinical routine. One of the affected areas, clearly applicable to the practice of clinical nutrition, is provision of tissue specific nutrients [1].


Parenteral Nutrition Clinical Nutrition Muscle Protein Synthesis Peptide Group Glutamine Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wilmore DW (1989) The practice of clinical mutrition: How to prepare for the future. JPEN 13: 337–343CrossRefGoogle Scholar
  2. 2.
    Fürst P (1983) Criteria underlying the formulation of amino–acid regimens: Established and new approaches. In: Kleinberger G, Deutsch E (eds) New Aspects of Clinical Nutrition. Karger, Basel, New York, pp 361–376Google Scholar
  3. 3.
    Fürst P (1991) Peptides in clinical nutrition. Clin Nutr 10 (suppl. 1): 19–24PubMedCrossRefGoogle Scholar
  4. 4.
    Adibi SA (1987) Experimental basis for use of peptides as substrates for parenteral nutrition: A review. Metabolism 36: 1001–1011PubMedCrossRefGoogle Scholar
  5. 5.
    Matthews DM (1987) Introduction. In: Adibi SA,Fekl W, Fürst P, Oehmke M (eds) Dipeptides as New Substrates in Nutrition Therapy. Karger, Basel, New York, pp 1–5Google Scholar
  6. 6.
    Laidlaw SA, Kopple JD (1987) Newer concepts of the indispensable amino-acids. Am J Clin Nutr 46: 593–605PubMedGoogle Scholar
  7. 7.
    Fürst P (1983) Intracellular muscle free amino-acids Their measurement and function. Proc Nutr Soc 42: 451–462PubMedCrossRefGoogle Scholar
  8. 8.
    Souba WW (1991) Glutamine: A key substrate for the splanchnic bed. Ann Rev Nutr 11: 285–308CrossRefGoogle Scholar
  9. 9.
    Fürst P, Stehle P (1993) The potential use of parenteral dipeptides in clinical nutrition. Nutr Clin practice (in press)Google Scholar
  10. 10.
    Stehle P, Bahsitta HP, Monter B, Fürst P (1990) Papain-catalyzed synthesis of dipeptides. A novel approach using free amino-acids as nucleophiles. Enzyme Microb Technol 12: 56–60Google Scholar
  11. 11.
    Monter B, Herzog B, Stehle P, Fürst P (1991) Kinetically controlled synthesis of dipeptides using ficin as biocytalyst. Biotechnol Appl Biochem 14: 183–191PubMedGoogle Scholar
  12. 12.
    Stehle P, Ratz, I, Fürst P (1989) In vivo utilization of intravenously supplied L-alanyl-L-glutamine in various tissues of the rat. Nutrition 5: 411–415PubMedGoogle Scholar
  13. 13.
    Karner J, Roth E, Ollenschläger G, Fürst P, Simmel A (1989) Glutamine-containing dipeptides as infusion substrates in the septic State. Surgery 106: 893–900PubMedGoogle Scholar
  14. 14.
    Tamada H, Nezu R, Imamura I, et al. (1992) The dipeptide alanyl-glutamine prevents intestinal mucosal atrophy in parenterally fed rats. JPEN 16: 110–116CrossRefGoogle Scholar
  15. 15.
    Fürst P (1985) Regulation of intracellular metabolism of amino acids. In: Bozetti F, Dionigi R (eds) Nutrition in Trauma and Cancer Sepsis. Karger, Basel, pp 21–53Google Scholar
  16. 16.
    Albers S, Wernerman J, Stehle P, Vinnars E, Fürst P (1988) Availability of amino-acids supplied intravenously in healthy man as synthetic dipeptides: Kinetic evaluation of L–alanyl-L-glutamine and glycyl-L-tyrosine. Clin Sei 75: 463–468Google Scholar
  17. 17.
    Druml W, Lochs H, Roth E, Hübl W, Balcke P, Lenz K (1991) Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans. Am J Physiol 260: E280–E285PubMedGoogle Scholar
  18. 18.
    Albers S, Wernerman J, Stehle P, Vinnars E, Fürst P (1989) Availability of amino-acids supplied by constant intravenous infusion of synthetic dipeptides in healthy man. ClinSci 76: 643–648Google Scholar
  19. 19.
    Hübl W, Druml W, Langer K, Lochs H (1989) Influence of molecular strueture and plasma hydrolysis on the metabolism of glutamine-containing dipeptides in humans. Metabolism 38 (suppl.l): 59–62PubMedCrossRefGoogle Scholar
  20. 20.
    Lochs H, Hübl W, Gasic S, Roth E, Morse EL, Adibi SA (1992) Glycylglutamine: Metabolism and effects on organ balances of amino-acids in postabsorptive and starved subjects. Am J Physiol Endocrinol Metab 262: E155–E160Google Scholar
  21. 21.
    Jepson MM, Bates PC, Broadbent P, Pell JM, Millward DJ (1988) Relatioship between glutamine concentration and protein synthesis in rat skeletal muscle. Am J Physiol 255: E166–E172PubMedGoogle Scholar
  22. 22.
    MacLennan PA, Brown RA, Rennie MJ (1987) A positive relationship between protein synthetic rate and intracellular glutamine concentration in perfused rat skeletal muscle. FEBS (Lett) 215: 187–191CrossRefGoogle Scholar
  23. 23.
    Stehle P, Zander J, Mertes N, et al. (1989) Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 1: 231–233PubMedCrossRefGoogle Scholar
  24. 24.
    Hammarqvist F, Wernerman J, von der Decken A, Vinnars E (1990) Alanyl-glutamine counteracts the depletion of free glutamine and the postoperative decline in protein synthesis in skeletal muscle. Ann Surg 212: 637–644PubMedCrossRefGoogle Scholar
  25. 25.
    Barua JM, Wilson E, Downie S,Weryk B, Cuschieri A, Rennie MJ (1992) The effect of alanylglutamine peptide supplementation on muscle protein synthesis in post-surgical patients receiving glutamine-free amino-acids intravenously. Proc Nutr Soc 51: 104AGoogle Scholar
  26. 26.
    Fürst P, Albers S, Stehle P (1990) Glutamine-containing dipeptides in parenteral nutrition. JPEN 14: 118S–124SCrossRefGoogle Scholar
  27. 27.
    Tremel H, Kienle B, Weilemann LS, et al. (1992) Glutamine dipeptide supplemented TPN maintains intestinal function in critically ill. Clin Nutr 1 l:(Abstr)Google Scholar
  28. 28.
    Newsholme EA, Newsholme P, Curi R, Challoner E, Ardawi MSM (1988) A role for muscle in the immune system and its importance in surgery, trauma, sepsis and burns. Nutrition 4: 261–268Google Scholar
  29. 29.
    Ziegler TR, Young LS, Benfell K, et al. (1992) Clinical and metabolic efficacy of glutaminesupplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116: 821–828Google Scholar
  30. 30.
    Karner J, Roth E (1990) Alanyl-glutamine infusions to patients with acute pancreatitis. Clin Nutr 9: 43–45PubMedCrossRefGoogle Scholar
  31. 31.
    Kinney JM, Fürst P, Elwyn DH, Carpentier YA (1988) The intensive care patient. In: Kinney JM, Jeejeebhoy KN, Hill GL, Owen OE (eds) Nutrition and Metabolism in Patient Care. WB Saunders, Philadelphia, London, pp 656–671Google Scholar
  32. 32.
    Vinnars E, Bergström J, Fürst P (1975) Influence of the postoperative State on the intracellular free amino-acids in human muscle tissue. Ann Surg 182: 665–671PubMedCrossRefGoogle Scholar
  33. 33.
    Khan K, Hardy G, McElroy B, Elia M (1991) The stability of L-glutamine in total parenteral nutrition solutions. Clin Nutr 10: 193–198PubMedCrossRefGoogle Scholar
  34. 34.
    Abumrad NN, Morse EL, Lochs H, Williams PE, Adibi SA (1989) Possible sources of glutamine for parenteral nutrition: Impact on glutamine metabolism. Am J Physiol 257: E228–E234PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • P. Fürst
  • P. Stehle

There are no affiliations available

Personalised recommendations